Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the month of May 2019. The report details a capital increase approved by the Board of Directors on May 2, 2019, resulting from the exercise of stock options granted in 2012 under the Company's Stock Option Plan.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure changes and historical share pricing.
- Capital Increase Amount: BRL 333,899.17
- New Capital Stock: BRL 57,799,629,900.50
- Shares Issued: 19,415 new common shares (no par value)
- Issuance Price: BRL 17.198 per share
- Potential Dilution: 0.00012%
Material Changes
The primary material change is the issuance of 19,415 new common shares. This transaction represents a negligible dilution of 0.00012% to existing shareholders. The filing includes historical market price data for the last three years, two years (quarterly), and six months (monthly), adjusted for interest on shareholder equity and dividends, but does not report operational changes.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, outlook, or discussion of risks and contingencies. It is a procedural notice regarding the verification of share issuance within the authorized capital limit.
Investor Verification Checklist
- Verify the total number of outstanding shares post-issuance to confirm the 0.00012% dilution calculation.
- Confirm the exercise price of BRL 17.198 against the market price on May 2, 2019, to assess the value of the options exercised.
- Review the Company's Stock Option Plan approved in July 2013 to understand the terms of the 2012 options exercised.
- Check subsequent filings for any material impact on the Company's capital structure or cash position from this specific issuance.